The North America aesthetic medicine market size was valued at USD 30.33 billion in 2025 and is projected to grow from USD 33.88 billion in 2026 to reach USD 82.23 billion by 2034, growing at a CAGR of 11.72% during the forecast period 2026–2034.
Aesthetic treatments, often known as cosmetic treatments, are non-surgical procedures that are intended to reduce the appearance of wrinkles, renew the skin, and make it look younger. Fine line and wrinkle reduction, fat reduction, stretch mark cures, scar therapy, skin oxygenation and resurrection, body contouring and firming, botulinum toxin, and skin repair are all covered under medical aesthetics. Aesthetic medicine is primarily concerned with modifying a person's visual look to their liking. Scars, excess fat, skin discolouration, skin laxity, moles, and wrinkles are all treated with this procedure.
A variety of invasive, minimally invasive, and non-invasive cosmetic procedures are used in aesthetic medicine. The global medical aesthetics market is growing as the aged population becomes more aware of such treatments and accepts novel treatments. Furthermore, evolving consumer attitudes around wellness, beauty, and healthy aging have increased aesthetic awareness and acceptability, boosting demand from new patient categories like men and millennials.
Download a Free Sample To learn more about this report,
GLP-1-Linked Body Contouring
The use of GLP-1 weight-loss medications is creating new demand for aesthetic procedures that address loose skin and changes in body shape after substantial weight loss. The transition toward weight-loss-linked aesthetic care is connecting medication-assisted weight management with body contouring, with ASPS reporting that more than 800,000 aesthetic patients used weight-loss medications in 2024 and 39% of GLP-1 patients surveyed were considering a surgical procedure. This shift is expanding the role of body contouring within the broader weight-management journey in North America.
Non-Hyaluronic Acid Injectable Adoption
The North America Aesthetic Medicine Market analysis shows that patients and providers are considering non-hyaluronic acid injectables for treatment goals such as collagen stimulation, firmness, and structural support. The transition toward calcium hydroxylapatite and poly-L-lactic acid formulations provides alternatives to traditional HA fillers, with the FDA recognizing both materials as absorbable dermal-filler options. This shift broadens injectable treatment options and supports more personalized approaches to facial rejuvenation.
Expansion of Aesthetic Clinics and Medspas and Medical Tourism for Aesthetic Procedures Drive Market
High Training and Certification Requirements for Practitioners and High Cost of Advanced Aesthetic Devices Restrain Market Expansion
High training and certification requirements increase the time and cost needed for practitioners to offer advanced aesthetic procedures. These requirements can limit the number of qualified professionals available to clinics, especially for specialized treatments and newer technologies. This workforce constraint can reduce service capacity and slow the adoption of advanced aesthetic procedures.
High costs of advanced aesthetic devices increase capital requirements for clinics investing in laser, energy-based, and other specialized treatment technologies.Large equipment investments can be difficult for smaller clinics to manage and may delay technology upgrades or new service launches.This financial barrier can limit technology adoption and constrain the expansion of aesthetic treatment capacity.
Aesthetic Treatment Training and Certification Services and Expansion of Aesthetic Treatments for Younger Consumers Offers Growth Opportunities
Aesthetic clinics, medical professionals, device manufacturers, and training providers are key beneficiaries, as practitioners need specialized skills for aesthetic procedures and technologies.Training and certification programs create revenue through course fees, workshops, certification programs, and advanced practitioner education. Companies such as Allergan Aesthetics and Merz Aesthetics provide professional education and training programs for aesthetic practitioners.
Aesthetic clinics, skincare providers, and treatment manufacturers are key beneficiaries, as younger consumers seek preventive skincare and minimally invasive aesthetic services. This segment creates revenue through tailored treatment packages, skincare products, maintenance programs, and repeat consultations. Companies such as Galderma and Merz Aesthetics offer aesthetic products and solutions that serve a broad range of consumer needs, supporting market growth.
Uneven Physician Oversight Across Medspas and Online Promotion of Unapproved Aesthetic Products Hinders Growth
Variation in physician supervision makes it difficult for companies to maintain consistent treatment standards across expanding medspa networks. This can increase operational risk and make partnerships, training, and service expansion more complex. Real-life example: A 2025 study found that only 22.52% of Missouri medspas examined had a physician on-site during cosmetic procedures
Online sellers can market aesthetic products directly to consumers and providers outside established distribution channels. This makes it harder for legitimate companies to control product presentation and compete against unauthorized offerings. Real-life example: In 2025, FDA warned a U.S. seller over unapproved high-concentration lidocaine products promoted for cosmetic procedures through its website and Instagram.
Invasive procedures include surgical aesthetic treatments that address body contouring, facial enhancement, and other cosmetic concerns requiring clinical intervention.Non-invasive procedures offer aesthetic improvements without major surgical intervention and include treatments such as skin rejuvenation, injectables, and energy-based therapies.
Request Customizationto receive a tailored report.
Hospitals provide aesthetic procedures within established healthcare facilities, particularly for treatments that require medical infrastructure and specialist expertise. Clinics and aesthetic centers provide specialized aesthetic treatments and offer consumers access to a broad range of cosmetic procedures in dedicated settings. Medspas combine aesthetic treatments with wellness-oriented services and provide convenient access to minimally invasive and non-invasive procedures.
Speak to an Analystto discuss market opportunities.
The North America Aesthetic Medicine Market accounted for the largest regional share of 30.4% in 2025. The region benefits from strong demand for minimally invasive and cosmetic procedures. The availability of advanced aesthetic technologies and established healthcare facilities further supports market growth.
The U.S. Census Bureau projects that by 2030, one in five Americans will be aged 65 or older, increasing the potential demand for aesthetic and age-related cosmetic treatments.Canada projects that the share of Canadians aged 65 and over will reach 21.9%–32.3% by 2073, compared with 18.9% in 2023, while the population aged 85 and over will also increase substantially, supporting long-term demand for aesthetic and wellness-related services
The North America Aesthetic Medicine Market is highly fragmented, with the market ecosystem comprising pharmaceutical companies, aesthetic device manufacturers, injectable product providers, dermatology clinics, cosmetic surgery centers, medical spas, hospitals, distributors, and independent aesthetic practitioners.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, competitive dynamics, and market opportunities. Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.
Docetaxel Market Size, Share, Growth, Analysis, Report, 2034
Phenylketonuria Market Size, Share, Growth, Analysis, Report, 2034
Ovarian Cancer Market Size, Share, Growth, Analysis, Report, 2034
Tulathromycin Market Size, Share, Growth, Analysis, Report, 2034
Renal Replacement Therapy Market Size, Share, Growth, 2034
Advanced Cancer Pain Management Market Size, Share, 2034
We are featured on:
sales@straitsresearch.com